Stockholm, Sweden

ESTRO 2026

Local time in host city

Programme

10 Sessions
: RTT
Sunday
May 17
17:00 - 18:00
A12
Adnan Şafek, Turkey;
Lee Harrison-Carey, United Kingdom
Proffered Papers
RTT
Sunday
May 17
10:30 - 11:30
A12
Adnan Şafek, Turkey;
Danielle Fairweather, United Kingdom
Proffered Papers
RTT
Saturday
May 16
10:30 - 11:30
A12
Anton Rink, The Netherlands;
Lisette Juul Sten, Denmark
Proffered Papers
RTT
Saturday
May 16
17:00 - 18:00
K11
Jennifer Thompson, United Kingdom;
Melanie Clarkson, United Kingdom
Poster Discussions
RTT
Tuesday
May 19
09:15 - 10:30
A12
Nicolle Gomes, Portugal;
Pooneh Porrangi, Sweden
This symposium explores how innovation is reshaping radiotherapy across the entire clinical pathway. It begins with multimodality imaging, highlighting the practical integration of MRI and other advanced imaging techniques to enhance precision in treatment planning. The focus then shifts to the evolving role of RTTs, examining how AI and automation are transforming clinical tasks into more evaluative and decision-driven responsibilities. Finally, implementation of simulator-free radiotherapy demonstrates how these advances translate into streamlined, patient-centred workflows. Together, these sessions provide a cohesive perspective on how technology, workforce evolution, and workflow redesign are driving the future of radiotherapy practice.
Symposium
RTT
Sunday
May 17
15:15 - 16:30
A12
Gunvor Dichmann Thyssen, Denmark;
Nicola Iosca, Italy
As radiotherapy evolves, a gap still exists between clinical intentions and patients' actual experiences. This session will explore how a true partnership between patients and professionals can reshape the field by integrating the patient’s voice. Key topics will address patient priorities, including effective communication, preparation for treatment, emotional support, and inclusive care. The landscape of co-creation in shared decision-making will be discussed, focusing on gaps between intention and practice. The symposium will consider how patient and public involvement (PPI) can be integrated into development strategies, highlighting its potential to bridge the gap and support more responsive, patient-centred services.
Symposium
RTT
Tuesday
May 19
11:00 - 12:15
A12
Ina Nilo, Switzerland;
Maeve Kearney, Ireland
Pitch Session
RTT
Monday
May 18
08:45 - 10:00
A12
Amanda Webster, United Kingdom;
Eva Van Weerd, The Netherlands
This symposium explores how different aspects of radiotherapy practice contribute to improving the patient experience. It highlights the role of RTT-led research in understanding what matters most to patients. The development of clinical academic career pathways is discussed, showing how RTTs can combine clinical work and research to directly improve care. Patient engagement is another key focus, demonstrating how continuity and supportive interactions with RTTs positively influence patient experience and satisfaction. Finally, the symposium examines how technological innovations, such as AI and adaptive radiotherapy, can support patient-centred care when guided by patient needs, multidisciplinary collaboration, and a focus on meaningful outcomes.
Symposium
RTT
Saturday
May 16
08:45 - 10:00
A12
Aoife Williamson, United Kingdom;
Lucy Siew Chen Davies, United Kingdom
This interdisciplinary symposium brings together clinical, technical, and research perspectives to examine the evolving role of CBCT‑-based dose calculations in adaptive radiotherapy (ART). It opens by outlining the key assumptions and uncertainties of CBCT‑-based dose computation and places them in context with the uncertainties already accepted in conventional planning. The session will then discuss three perspectives from different radiotherapy centres that have implemented, or are actively developing, CBCT-based recalculation workflows and CBCT-based adaptive planning. The first perspective reviews the transition from traditional TLP utilisation to CBCT‑-based dose assessment and examines how responsibilities are distributed within offline ART workflows. A head and neck workflow example illustrates how multidisciplinary roles (particularly RTT involvement) may evolve and where practical limitations remain. A second centre-based perspective introduces continuous, automated dose monitoring for patient specific quality assurance (PSQA). Using a lung dataset, it compares anatomical reporting with automated dose‑-based triggers, highlighting how numerical monitoring can reveal underreported changes and support scalable automation amid staffing pressures. The final presentation shares experience with trigger‑-based offline ART, discussing workflow development, patient‑-selection strategies, and the ongoing need for clearer criteria. Despite challenges, evidence shows that offline ART can deliver meaningful clinical benefit while underscoring the continued need for development in this area.
Symposium
RTT
Monday
May 18
15:15 - 16:30
A12
Jenna Dean, Australia;
Mirjam Mast, The Netherlands
Brief background literature instigating the use of rectal preparation, rectal preparation methods, their effectiveness, and patient experience The patient group we stopped rectal preparation for, supporting patient information, documentation, and training Application of and results from a clinical audit of rectal volume and prostate motion without rectal preparation Development of and results from a patient’s experience preparing for prostate cancer radiotherapy survey. Discussion on stopping rectal preparation, personalising preparation, and clinical impact Background-Historical standards for immobilisation of head and neck cancer with a brief explainer of PTV expansions (Van Herk) and toxicities associated with head and neck RT Summary of Head and Neck Immobilisation-Literature Review Table Discussion of the OPEN Trial-this study was discussed at ESTRO plenary last year, however we now have full results which I can discuss. A discussion point from the OPEN Trial results-the potential for personalised margins through recognising patients who move less than the anticipated population based PTV expansion Discuss the feasibility study currently being run in SLRON exploring personalised margins A discussion of qualitative research I conducted with Head and Neck cancer patients on the open trial, highlighting the patient voice-need for shared decision making and how immobilisation and margins may be a time point where patients can be involved in treatment related decisions. Importance of respiratory motion reduction and overview of existing motion management techniques The Mechanically Assisted Non-Invasive Ventilation (MANIV) technique: Principles and implementations Clinical indications and contraindications IGRT image comparison: with and without MANIV Staff training and workflow adaptation Staff feedback and experience Patient experience and feedback Future developments and perspectives
Symposium
RTT
+(event:"efd886fc-e357-f011-bec1-6045bddff504") AND +(track:"0dd986fc-e357-f011-bec1-6045bddff504")